These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28268078)

  • 1. Comparative study of the B-SAQ, OAB-V8 and OAB-V3 questionnaires as screening tools for overactive bladders in clinical practice.
    Angulo JC; Calderín MP; Fernández Y; González M; Gómez E; Herreros MB; Peñasco P; Zapatero M; Dorado JF
    Actas Urol Esp; 2017; 41(6):383-390. PubMed ID: 28268078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychometric validation of the OAB-V8 and OAB-V3 scales for the screening of patients with probable overactive bladder in the Spanish population].
    Brenes FJ; Angulo JC; Ochayta D; Rejas J; Arumí D; Cañadas A; Lizarraga I
    Med Clin (Barc); 2014 Dec; 143(12):521-9. PubMed ID: 24725856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison study of two lower urinary tract symptoms screening tools in clinical practice: the B-SAQ and OAB-V8 questionnaires.
    Basra RK; Cortes E; Khullar V; Kelleher C
    J Obstet Gynaecol; 2012 Oct; 32(7):666-71. PubMed ID: 22943714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should we address the diagnosis of overactive bladder in women?
    Jiménez Cidre MA; López-Fando L; Esteban M; Franco A; Arlandis S; Castro D; Prieto L; Salinas J; Gutiérrez C; Gutiérrez Baños JL; Cambronero J;
    Actas Urol Esp; 2016; 40(1):29-36. PubMed ID: 26493277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and characterization of overactive bladder detected in a population in Madrid with self-administered OAB-V3 questionnaire in Primary Care].
    Angulo JC; Calderín MP; Fernández Y; González M; Gómez E; Herreros MB; Peñasco P; Zapatero M; Dorado JF
    Aten Primaria; 2018 Feb; 50(2):79-87. PubMed ID: 28751103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?
    Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-finding tools for the diagnosis of OAB in women: A narrative review.
    Malde S; Kelly S; Saad S; Sahai A
    Neurourol Urodyn; 2020 Jan; 39(1):13-24. PubMed ID: 31578764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2022; 46(1):41-48. PubMed ID: 34848162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of main diagnosis tools in women with overactive bladder. Clinical history, micturition diary and urodynamic study.
    López-Fando L; Carracedo D; Jiménez M; Gómez de Vicente JM; Martínez L; Gómez-Cañizo C; Gómez V; Burgos FJ
    Actas Urol Esp; 2015; 39(1):40-6. PubMed ID: 24735898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Spanish version of the "Bladder control Self-Assessment Questionnarie" (B-SAQ). A new screening instrument for lower urinary tract dysfunction].
    Espuña Pons M; Puig Clota M; Rebollo Alvarez P
    Actas Urol Esp; 2006; 30(10):1017-24. PubMed ID: 17253070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: the Cuestionario de Autoevaluación del Control de la Vejiga (CACV).
    Lugo Salcedo F; Sánchez Borrego R;
    Int Urogynecol J; 2013 Sep; 24(9):1559-66. PubMed ID: 23443344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
    Villacampa F; Ruiz MA; Errando C; Arlandis S; Arumí D; Lizarraga I; Rejas J
    Int Urogynecol J; 2013 Apr; 24(4):573-81. PubMed ID: 23111865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment.
    Bunyavejchevin S
    J Obstet Gynaecol Res; 2015 Jun; 41(6):957-61. PubMed ID: 25773663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory.
    Peterson AC; Sehgal A; Crump RT; Baverstock R; Sutherland JM; Carlson K
    Neurourol Urodyn; 2018 Mar; 37(3):1095-1100. PubMed ID: 28976596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schooling impacts on the overactive bladder diagnosis in women.
    Ferreira LR; Gameiro MO; Kawano PR; Yamamoto HA; Guerra R; Reis LO; Amaro JL
    Int Braz J Urol; 2017; 43(6):1129-1135. PubMed ID: 28727389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2021 Jul; ():. PubMed ID: 34332808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, beliefs, and coping strategies among older patients with overactive bladder.
    Blasco P; Valdivia MI; Oña MR; Roset M; Mora AM; Hernández M
    Neurourol Urodyn; 2017 Mar; 36(3):774-779. PubMed ID: 27120009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes.
    Angulo JC; Brenes FJ; Lizarraga I; Rejas J; Trillo S; Ochayta D; Arumi D
    Actas Urol Esp; 2016 Apr; 40(3):173-82. PubMed ID: 26811022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the bladder control self-assessment questionnaire (B-SAQ) in men.
    Sahai A; Dowson C; Cortes E; Seth J; Watkins J; Khan MS; Dasgupta P; Cardozo L; Chapple C; De Ridder D; Wagg A; Kelleher C
    BJU Int; 2014 May; 113(5):783-8. PubMed ID: 24131479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.